Načítá se...
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer’s disease (AD), perhaps even before amyloid-β accumulation or brain atrophy. This evidence, consistent with the vascular hypothesis of AD, implicates cerebral blood fl...
Uloženo v:
| Vydáno v: | Cell Mol Neurobiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5278904/ https://ncbi.nlm.nih.gov/pubmed/26898552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10571-015-0261-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|